Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2002, p. 943-950, Vol. 40, No. 3
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.3.943-950.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Institut de Pharmacologie et Biologie Structurale (UMR5089), CNRS/Université Paul Sabatier Toulouse III,1 Institut National des Sciences Appliquées, Complexe Scientifique de Rangueil, F-31077 Toulouse Cedex, France,3 Department of Medical Biochemistry, University of Stellenbosch Medical School, Tygerberg 7505, South Africa2
Received 23 July 2001/ Returned for modification 28 October 2001/ Accepted 30 December 2001
|
|
|---|
|
|
|---|
This worldwide resurgence of tuberculosis has strengthened the need for rapid and specific diagnostic tools to control its spread. Delay in diagnosis results, first, in late initiation of antitubercular therapy and, second, in prolonged transmission of the infection.
Until recently, the diagnosis of tuberculosis was based on clinical features and microbiological assays, radiological examinations, immunological tests, microscopy identification, or in vitro cultures (37). Acid-fast staining microscopy of specimens combined with isolation and culture of the bacilli remains the "gold standard" method to specifically identify mycobacteria. Because of the low growth rate of M. tuberculosis, this method is time-consuming, and the diagnosis can take up to 8 weeks.
More recently, molecular approaches have been designed to ensure early detection of M. tuberculosis in clinical samples. These methods include DNA amplification by strand displacement amplification (35) or by PCR of M. tuberculosis-specific genes. The use of adequate oligonucleotide pairs to amplify target sequences such as rRNA 16S, IS6110, mtp40, or the senX3-regX3 intergenic region has demonstrated the reliability and high sensitivity of PCR diagnosis (3). Moreover, technical adaptations of PCR protocols (13, 25, 40) have made it possible to detect mycobacteria directly from clinical samples, such as sputum, blood, urine, and cerebrospinal or pleural fluid. These nucleic acid-based methods have been found to be more sensitive than conventional methods and were able to detect even small numbers of M. tuberculosis cells (1, 12, 18). However, the choice of the most favorable target sequence is controversial, since results from different clinical studies evaluating the various amplification assays were divergent concerning their specificity and sensitivity (11, 17, 20, 31, 39; S. H. Gillespie, T. D. McHugh, and L. E. Newport, Letter, J. Clin. Microbiol. 35:799-801, 1997). To optimize specificity and sensitivity, the target sequence should be present in all strains of the M. tuberculosis complex, with a high degree of sequence conservation between strains to avoid false-negative reactions, and should be absent in all other mycobacterium species, thereby eliminating the chance of false-positive results.
In a previous work undertaken to clarify the role of RecA inteins in mycobacteria (32), we showed that the insertion site and the sequence of the recA intein from M. tuberculosis (8) are unique among mycobacteria. Similarly, the M. tuberculosis pps1 gene (6) possesses an insertion sequence with no homolog known to date in other mycobacterial species (Inbase, the New England Biolabs intein database, at http://www.neb.com/neb/inteins/). The species specificities of both of these invading sequences make them potential targets for PCR amplification. Moreover, since inteins are potential endonucleases (Inteins-Protein Introns web site at http://bioinfo.weizmann.ac.il/
pietro/inteins/), the search for their specific functions could lead to a new molecular approach to diagnose tuberculosis.
In the present study, we show first that both intein coding sequences disrupting recA and pps1 genes from M. tuberculosis are specific to the M. tuberculosis complex and can thus effectively be used as DNA target sequences in a PCR-based diagnosis. In addition, we demonstrated that, unlike the RecA intein, the Pps1 intein MtuPps1 exhibits an endonuclease activity, which could provide a new tool to unequivocally detect and identify members of the M. tuberculosis complex.
|
|
|---|
![]() View larger version (68K): [in a new window] |
FIG. 1. Specificity of the MtuRecA intein. (A) Location of intein insertion sites in mycobacterial recA genes. Arrows represent the oligonucleotides used to amplify gene fragments. The positions of the RecA-a and RecA-b sites and of oligonucleotides are indicated as the number of base pairs from the translation start site in the M. tuberculosis H37Rv gene. (B) PCR amplification with R1 and R2 oligonucleotides from genomic DNA of nine species of mycobacteria. (C) PCR amplification with R1 and R3 oligonucleotides from genomic DNA of 27 species of mycobacteria.
|
Genomic DNA from the MT103 strain of M. tuberculosis was obtained from Institut Pasteur (Paris, France).
PCR assays. The primers R3 (5'ACCACGGCGATCTTCATCAACCAGCT 3'), R2 (5' GCGTCGGTGCGCATGGACGTGCG 3'), and R1 (5' AGGATGTCGAACTCGGCCAGCTTGAA 3') correspond to the M. tuberculosis recA gene sequence or its complementary sequence at positions 562 to 587, 658 to 680, and 765 to 791, respectively, according to the M. tuberculosis H37Rv gene sequence. The primers P2 (5' CATCCGCAACACCTACGACCGG 3'), P3 (5' GAACATGGGCCZGTTCGAGCGGACG 3'), and P1 (5' GTCGTTGTTCGACCAGTTCTGGATGGT 3') correspond to the M. tuberculosis pps1 gene sequence or its complementary sequence at positions 357 to 378, 687 to 711, and 844 to 870, respectively, according to the M. tuberculosis H37Rv gene sequence.
PCR amplifications were performed with Taq DNA polymerase in a mixture containing 10 mM Tris-HCl [pH 8.3], 1.5 mM MgCl2, 50 mM KCl, and 0.2 mM deoxynucleoside triphosphates (dNTPs), with 5 µl of the genomic DNA preparation as a DNA template. Several PCR assays were performed under different reaction conditions with regard to oligonucleotide concentrations and hybridization temperature to ensure amplification specificity.
Cloning of MtuRecA and MtuPps1 coding sequences. The entire coding sequences of MtuRecA and MtuPps1 inteins were amplified by PCR from genomic DNA of the MT103 strain of M. tuberculosis with oligonucleotide pairs MtuRecA-ATG (5' ATGTGCCTCGCAGAGGGGACT 3') and MtuRecA-3' (5' GTTGTGCACGACAACCCCTTC 3') and MtuPps1-ATG (5' ATGTGCCTGCCCGCCGGC 3') and MtuPps1-3' (5' GTTGTGCACGGCGAACCCGT 3'), respectively. For this purpose, 1 µl (200 ng) of genomic DNA was incubated with Taq DNA polymerase in a mixture containing 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl2, 50 mM KCl, 0.2 mM dNTPs, and 10 pmol of each oligonucleotide in a 50-µl mix, which was incubated as follows: 10 min at 92°C; 29 times for 1 min at 92°C, 1 min at 55°C, and 1.5 min at 72°C; and, finally, 5 min at 72°C.
These sequences were inserted in the pCR T7/CT-TOPO plasmid (Invitrogen). The resulting constructs allow the expression of both inteins fused to C-terminal V5 and six-His tags under the regulation of T7 promoter and T7 RNA polymerase in Escherichia coli.
Production and extraction of MtuPps1 and MtuRecA inteins. E. coli BL21(De3)(pLysS) bacteria were transformed with the two expression vectors. Bacteria were grown at 30°C in Luria broth culture medium supplemented with 100 µg of ampicillin (Sigma) and 30 µg of chloramphenicol per ml until they reached the exponential phase. Thus, the induction of MtuRecA or MtuPps1 expression with 1 mM IPTG (isopropyl-ß-D-thiogalactopyranoside) (Sigma) was performed for 4 h at 37°C or for 6 h at 30°C, respectively. Cells were lysed in 20 mM sodium phosphate (pH 7.5) by six cycles of freezing and thawing. The lysate was centrifuged at 10,000 x g for 45 min to separate the soluble intein from insoluble proteins. The soluble fraction was dialyzed against a mixture containing 10 mM Tris-HCl (pH 7.5), 0.1 mM EDTA, 1 mM dithiothreitol, 200 µg of bovine serum albumin per ml, and 50 mM NaCl. A protein extract from nontransformed BL21(De3)(pLysS) was collected under similar culture and extraction conditions and used as a negative control in endonuclease assays.
Protein extracts were quantified by the Bradford's method (2). Samples containing 0.5 to 5 mg of proteins per ml were denatured at 95°C for 2 min in a sodium dodecyl sulfate (SDS)-urea-ß-mercaptoethanol buffer and analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) (homogenous, 10% polyacrylamide) according to the method of Laemmli (21). Separated proteins were electrically transferred to nitrocellulose membrane (BA45; Schleicher and Schuell) in a semidry apparatus (4). Membranes were incubated for 30 min in Tris-buffered saline (TBS; 10 mM Tris-HCl [pH 8], 137 mM NaCl) containing 1% Tween 20 and 10% nonfat dry milk for 1 h with anti-V5 antibodies (Invitrogen), diluted 1:5,000 in TBS containing 1% Tween 20 and 1% nonfat dry milk, and for 1 h with a peroxidase-labeled antimouse immunoglobulin G conjugate diluted 1:10,000 in the same buffer. A detection reaction with chemiluminescent substrate was performed with the ECL enhanced chemiluminescence detection kit according to the manufacturer's instructions (Amersham-Pharmacia Biotech).
Endonuclease assays. To assay MtuRecA and MtuPps1 for endonuclease activity, the 40-bp DNA sequences spanning their homing site were inserted between XbaI and HindIII restriction sites of plasmid pUC19. Partially complementary oligonucleotide pairs MtuRecA-XbaI (5' CTAGATCAAGGTCGTCAAGAACAAGTGTTCGCCCCCCTTCAAGCA 3') and MtuRecA-HindIII (5'AGCTTGCTTGAAGGGGGGCGAACACTTGTTCTTGACGACCTTGAT3') and MtuPps1-XbaI (5' CTAGAACGTGCACTACGTAGAGGGTCGCACCGCACCGATCTACAAAA 3') and MtuPps1-HindIII (5' AGCTTTTGTAGATCGGTGCGGTGCAGCCCTCTACGTAGTGCACGTT 3') were annealed by boiling a mix of 1 nmol of each oligonucleotide in a mixture of 10 mM Tris-HCl (pH 7.5) and 50 mM NaCl for 5 min and slow cooling to room temperature. The annealed oligonucleotides were then inserted in pUC19 overdigested by HindIII and XbaI (New England Biolabs). The resulting constructs, substrates 1 and 2, were sequenced. They were linearized by ScaI and extracted from a 1% agarose gel in TBE (90 mM Tris-borate, 2 mM EDTA) buffer, and the linear substrates were diluted in water to a concentration of 100 ng/µl for cleavage assays.
Endonuclease activity assays were performed in a final volume of 10 µl, in various reaction buffers, and at temperatures ranging from 15 to 50°C. Moreover, the quantity of proteins added to the reaction mix varied from 25 ng to 5 µg. The reaction mixtures were analyzed on a 1% agarose gel in TBE buffer.
Nucleotide sequence accession numbers. The GenBank/EMBL accession numbers for the RecA and Pps1 inteins are X58485 and AL021184, respectively.
|
|
|---|
In a parallel experiment, amplification with primers R1 and R3 generated a 230-bp fragment spanning both RecA-a and RecA-b sites, allowing the confirmation of the absence of intein in 27 other mycobacterial species (Fig. 1C).
In order to check whether the R1-R2 primer pair can be used for tuberculosis screening, we performed an amplification reaction using genomic DNA preparations from 36 different M. tuberculosis strains isolated from patients with confirmed tuberculosis (36) and from 10 strains of M. bovis. The 1,454-bp specific fragment was generated with all of the M. tuberculosis or M. bovis strains (not shown), implying that all strains of M. tuberculosis and M. bovis tested possess the intein in the RecA-a site of the recA gene in their genomes.
The MtuPps1 intein gene is specific for the M. tuberculosis complex. To date, three intein insertion sites have been described in the pps1 gene (33) (Inbase, the New England Biolabs intein database): Pps1-a, Pps1-b, and Pps1-c are the respective intein insertion sites of M. leprae, M. tuberculosis, and Mycobacterium gastri inteins (Fig. 2A). To control for the specificity of the M. tuberculosis intein amplification, we searched for the presence of intein sequences in 35 different mycobacterial species by PCR amplification of a 524-bp sequence spanning the three insertion sites. P1 and P2 primers were designed according to the conserved pps1 gene sequences in M. tuberculosis and M. leprae. As shown in Fig. 2B, intein was absent from 15 of our mycobacterial species, based on the amplification of a fragment of approximately 500 bp, while the presence of an intein in M. gastri, M. tuberculosis, and M. bovis was demonstrated by the amplification of larger fragments. In eight Mycobacterium species, namely M. chitae, M. fallax, M. farcinogenes, M. gordonae, M. parafortuitum, M. senegalense, M. thermoresistibile, and M. shimoidei, no amplified DNA was obtained, whatever the amplification conditions. Additionally, nonspecific amplified fragments were obtained from genomic DNA from the nine remaining species (M. gadium, M. chelonae, M. fortuitum, M. kansasii, M. marinum, M. peregrinum, M. scrofulaceum, M. xenopi, and M. cookii) under extremely permissive conditions of PCR, while no amplification was obtained under more stringent PCR conditions. That may be due to the lack of a pps1 gene or to the strong divergence of the sequence of the pps1 gene in these 17 mycobacterial species.
![]() View larger version (58K): [in a new window] |
FIG. 2. Specificity of MtuPps1 intein. (A) Location of intein insertion sites in mycobacterial pps1 genes. Arrows represent the oligonucleotides used to amplify gene fragments. The positions of Pps1-a, Pps1-b, and Pps1-c sites and of oligonucleotides are indicated as number of base pairs from the translation start site in the M. tuberculosis H37Rv gene. (B) PCR amplification with P1 and P2 oligonucleotides from genomic DNA of 18 species of mycobacteria. (C) PCR amplification with P1 and P3 oligonucleotides from genomic DNA of three species of mycobacteria.
|
Both oligonucleotide pairs (P1-P2 and P1-P3) were used to amplify genomic DNA from 36 M. tuberculosis and 10 M. bovis strains (not shown). Interestingly, the identification of approximately 1,600- and 1,300-bp fragments, respectively, in the 46 amplification reactions confirmed the presence of the pps1 intein in all of the M. tuberculosis and M. bovis strains tested.
Combined detection of recA and pps1 inteins by PCR. In an additional PCR assay, we tried to simultaneously amplify recA and pps1 genes in a one-tube reaction for a combined detection of both M. tuberculosis-specific inteins. pps1 and recA gene fragments were amplified from M. tuberculosis H37v genomic DNA by using P1 and P3 and R1 and R2 oligonucleotide pairs, respectively, either in separate tubes or in the same reaction tube. As expected, the two specific fragments of 1,260 and 1,454 bp, resulting from the amplification of pps1 and recA, respectively, were obtained when both oligonucleotide pairs were present in the reaction mix (Fig. 3).
![]() View larger version (63K): [in a new window] |
FIG. 3. PCR amplification with the P1-P3 oligonucleotide pair (lane 1), the R1-R2 oligonucleotide pair (lane 3), or both oligonucleotide pairs (lane 2) from genomic DNA of M. tuberculosis H37Rv.
|
![]() View larger version (73K): [in a new window] |
FIG. 4. Expression of MtuPps1 and MtuRecA inteins in E. coli. Tagged inteins were detected by Western blotting of the SDS-PAGE (10% polyacrylamide) gels used to separate proteins from soluble (S) and insoluble (I) fractions of MtuPps1 and MtuRecA extracts and immunologic detection by using anti-V5 antibody.
|
![]() View larger version (33K): [in a new window] |
FIG. 5. Endonuclease assays. (A) DNA substrates for MtuPps1 and MtuRecA. The sequences of MtuPps1 and MtuRecA homing sites (HS) inserted in pUC19 (the sequence of which appears in boldface) are underlined. (B) Cleavage assay for MtuPps1. One hundred nanograms of linearized substrate 2 was incubated with either 2.5 µg of the crude extract of MtuPps1 (+) or 2.5 µg of a crude extract of nontransformed E. coli BL21(De3)(pLysS) (-), for 1 h at 37°C, in 10 mM Tris-HCl (pH 8) buffer containing 10 mM MgCl2 and 25 mM KCl. Substrate (S2; 2,730 bp) and products (P; 940 and 1,790 bp) were separated on a 1% agarose gel in TBE buffer. (C) Cleavage assay for MtuRecA. One hundred nanograms of linearized substrate 1 was incubated with either 2.5 µg of the crude extract of MtuRecA (+) or 2.5 µg of a crude extract of nontransformed E. coli BL21(De3)(pLysS) (-), for 1 h at 37°C, in 10 mM Tris-HCl (pH 8) buffer containing 10 mM MgCl2 and 25 mM KCl. The reaction mixture was analyzed on a 1% agarose gel in TBE buffer.
|
|
|
|---|
In order to reduce the delay in diagnosis, several methods have been developed. Semiautomated liquid culture systems, such as the BACTEC radiometric method or MB/Bact and MGIT systems, are able to detect mycobacterial slow growers within 10 to 14 days. While several of these growth detection methods have demonstrated good performance comparable to standard methods (23, 26), the necessity for a heavy and expensive apparatus limits their use in poor countries. Moreover, additional tests may be necessary to finally identify the mycobacterial species. Immunologic or enzymatic assays and phage systems (5, 30) were also proposed, but are generally nonuniformly applicable or lack specificity and/or sensitivity.
One of the most important technical advances in diagnosis of tuberculosis is the development of molecular methods. The detection, through PCR amplification, of a DNA sequence specifically present in the genomes of members of the M. tuberculosis complex has the potential to overcome the sensitivity and specificity limitations of other diagnostic methods. However, while protocols used to amplify DNA from mycobacteria present in a wide range of samples have been greatly optimized, the choice of the target sequence remains controversial. Various PCR assays have been suggested; these include amplification of sequences encoding mycobacterial antigens, insertion sequences, rRNA, and intergenic regions.
Among the proposed targets, the 16S rRNA gene is the sequence amplified by commercial kits: i.e., the Roche AMPLICOR MTB (Roche Diagnostic Systems, Somerville, N.J.) and the Gen-Probe AMTB (Gen-Probe, Inc., San Diego, Calif.). Although the performance of each of these tests is excellent, their specificity cannot be optimal, since the target gene is present in all mycobacterial species. Hence, the discrimination between mycobacteria necessitates hybridization with specific DNA probes (16, 41). Indeed, the use of these tests was initially restricted to acid-fast bacillus-positive specimens (1).
The most popular target sequence is the insertion sequence IS6110, also known as IS986 or IS987 (27). Even if some studies demonstrated excellent diagnostic results (15, 17), the specificity of IS6110-based assays is controversial (11; Gillespie et al., Letter). The multicopy IS6110 sequence, identified in the majority of M. tuberculosis strains, accounts for the high sensitivity of the amplification procedure; however, strains with few or no copies of this insertion sequence have also been isolated (42). Moreover, since this sequence is a member of the IS3 family, the most widespread group of insertion sequences in bacteria, homologous sequences have been found in nontuberculous mycobacteria (20, 28). Hence, even if the use of various primer sets to amplify different segments of the sequence may enhance the specificity of the test, the existence of strains lacking this sequence seriously compromises the use of IS6110-based PCR for tuberculosis diagnosis.
Little is known about the diagnosis based on the amplification of the MPB64- and Hsp65-encoding genes, but these procedures have shown poor sensitivity and require an additional oligonucleotide hybridization step for the detection of the amplified fragments. Therefore, the specificity remains rather uncertain (3, 22). The mtp40 gene detection has been thoroughly studied. A comparative study showed that mtp40 is more reliable than the IS6110-based amplification test (19). However, Weil et al. (39) demonstrated that this gene is not present in all strains of M. tuberculosis. Moreover, since this gene is absent in the other species of the M. tuberculosis complex (9), the diagnosis could fail to recognize many cases of tuberculosis. Hence, it should instead be used to discriminate between M. tuberculosis and other species of the M. tuberculosis complex (10).
More recently, an interesting alternative was found in the amplification of the senX3-regX3 intergenic region (24, 34), since this sequence is distributed in all strains of the M. tuberculosis complex. However, one should note that, first, this sequence is also found in M. leprae genome, and, second, the length and the sequence of this intergenic region are variable, making interpretation of PCR results quite ambiguous.
In the present study, we demonstrated the feasibility of using intein coding sequences as a target for PCR diagnosis, since the M. tuberculosis recA and pps1 intein sequences are specific for members of the M. tuberculosis complex (Fig. 1 and 2). Indeed, only the recA genes of M. tuberculosis and M. bovis were found to be interrupted by an intein sequence at the RecA-a site, while a total of 34 different mycobacterial species have failed to demonstrate this insertion. Likewise, the MtuPps1 intein sequence embedded at the Pps1-b site of the M. tuberculosis pps1 gene was absent from 16 other mycobacterial species and was not detected in 17 other species. Moreover, all of the M. tuberculosis and M. bovis strains tested in this study harbor both intein sequences, suggesting a widespread distribution of these invading sequences among the members of the M. tuberculosis complex.
The primer pairs were designed in order to amplify a fragment of the host gene, spanning the intein insertion site, rather than the intein sequence itself. Hence, a DNA fragment has to be amplified even in absence of an intein coding sequence, so that it is possible to control the absence of inhibitory substances in the PCRs. The recA gene was efficiently amplified in all of the mycobacterial species and strains tested, and a 1,320-bp-longer fragment was obtained only in presence of M. tuberculosis or M. bovis DNA (Fig. 1). These results indicated that the recA gene is present in all 36 of the species, a result probably related to the essentiality of RecA recombinase in mycobacteria, as suggested by Frischkorn and collaborators and Papavinasasundaram and collaborators (14, 29). Moreover, the amplification yields were rather high, suggesting that the sensitivity of the PCR diagnosis would be quite good, even if the target sequences are present in single copy in the M. tuberculosis genome.
In the case of pps1, no amplification was obtained for some mycobacterial species. Since recA amplification was performed from the same DNA preparations, these negative reactions were not attributed to the presence of any inhibitory substances. The absence of amplified fragment could be explained by the absence of the pps1 gene in these mycobacteria. However, this hypothesis is unlikely, since inteins are generally present in essential host proteins, and a previous study suggested an important role of Pps1 in mycobacteria (33). Hence, a probable explanation may reside in sequence divergences of pps1 genes between various mycobacterial species, hindering the hybridization of primers. Nevertheless, the detection of a 1,300-bp-long fragment in the presence of M. tuberculosis and M. bovis DNA, compared to the 200-bp fragment obtained in presence of other mycobacterial species (Fig. 2), allowed the specific identification of M. tuberculosis and M. bovis.
As formerly suggested by Brisson-Noël and collaborators (3), two amplification assays should be done in parallel to avoid misinterpretation of PCR results, without the need for an additional internal amplification control. Here, we propose the simultaneous detection of MtuRecA- and MtuPps1-specific sequences. The combination of amplifications of both recA and pps1 genes, in a multiprimer PCR (Fig. 3), can ensure the rapid and specific detection of M. tuberculosis.
Moreover, the detection of the specific endonuclease activity of MtuPps1 intein could represent a new molecular approach to identify M. tuberculosis. One can imagine a PCR amplification followed by in vitro translation of the intein and a specific cleavage assay by using linear substrate S2 (Fig. 5). Effectively, the detection of the cleavage activity is even more specific than the sole PCR amplification of the intein sequence and, concerning specificity, should provide excellent results. However, the sensitivity of such a test is still to be determined. In vitro transduction assays have to be performed and optimized with this particular mycobacterial sequence in order to validate this new diagnostic approach.
In conclusion, the results described here highlight that the specificity of M. tuberculosis and M. bovis inteins found in RecA and Pps1 host proteins should be considered as an important new molecular tool for diagnosis of tuberculosis.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»